Arvinas (ARVN) Interest Coverage Ratio (QoQ) (2017 - 2021)
Powered by 
Analysis
Arvinas (ARVN) Interest Coverage Ratio (QoQ) (2017 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Arvinas | 609.44 Mn | 41.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 87.91% |
| Sep 30, 2021 | 8.86% |
| Jun 30, 2021 | -148.92% |
| Mar 31, 2021 | -235.88% |
| Dec 31, 2020 | 60.89% |
| Sep 30, 2020 | -19.88% |
| Jun 30, 2020 | -13.12% |
| Mar 31, 2020 | -2.73% |
| Dec 31, 2019 | -683.50% |
| Sep 30, 2019 | 129.71% |
| Jun 30, 2019 | -20.91% |
| Mar 31, 2019 | 2.72% |
| Dec 31, 2018 | 40.00% |
| Sep 30, 2018 | -32.85% |
| Jun 30, 2018 | -114.99% |
| Mar 31, 2018 | 13.40% |
| Dec 31, 2017 | 11.67% |
| Sep 30, 2017 | -1.22% |
| Jun 30, 2017 | -12.52% |